Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.

Saved in:
Bibliographic Details
Title: Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.
Authors: Solanich X; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Antolí A; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Rocamora-Blanch G; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Padullés N; Department of Pharmacy, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Fanlo-Maresma M; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Iriarte A; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Mitjavila F; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Capdevila O; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Riera-Mestre A; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Bas J; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Vicens-Zygmunt V; Department of Pneumology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Niubó J; Department of Microbiology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Calvo N; Department of Diagnostic Imaging, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Bolivar S; Department of Diagnostic Imaging, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Rigo-Bonnin R; Department of Clinical Laboratory, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Mensa-Vilaró A; Department of Immunology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Arregui L; HUB-ICO-IDIBELL Biobank, Spanish Clinical Research Network, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Tebe C; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Biostatistics, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Videla S; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Clinical Pharmacology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Clinical Research and Clinical Trial Unit (UICEC-IDIBELL), Spanish Clinical Research Network, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Hereu P; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Clinical Pharmacology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Clinical Research and Clinical Trial Unit (UICEC-IDIBELL), Spanish Clinical Research Network, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Corbella X; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain.
Source: Frontiers in medicine [Front Med (Lausanne)] 2021 Jun 14; Vol. 8, pp. 691712. Date of Electronic Publication: 2021 Jun 14 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34195214
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Solanich+X%22">Solanich X</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Antolí+A%22">Antolí A</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rocamora-Blanch+G%22">Rocamora-Blanch G</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Padullés+N%22">Padullés N</searchLink>; Department of Pharmacy, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Fanlo-Maresma+M%22">Fanlo-Maresma M</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Iriarte+A%22">Iriarte A</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mitjavila+F%22">Mitjavila F</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Capdevila+O%22">Capdevila O</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Riera-Mestre+A%22">Riera-Mestre A</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bas+J%22">Bas J</searchLink>; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Vicens-Zygmunt+V%22">Vicens-Zygmunt V</searchLink>; Department of Pneumology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Niubó+J%22">Niubó J</searchLink>; Department of Microbiology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Calvo+N%22">Calvo N</searchLink>; Department of Diagnostic Imaging, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bolivar+S%22">Bolivar S</searchLink>; Department of Diagnostic Imaging, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rigo-Bonnin+R%22">Rigo-Bonnin R</searchLink>; Department of Clinical Laboratory, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mensa-Vilaró+A%22">Mensa-Vilaró A</searchLink>; Department of Immunology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Arregui+L%22">Arregui L</searchLink>; HUB-ICO-IDIBELL Biobank, Spanish Clinical Research Network, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Tebe+C%22">Tebe C</searchLink>; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Biostatistics, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Videla+S%22">Videla S</searchLink>; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Clinical Pharmacology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Clinical Research and Clinical Trial Unit (UICEC-IDIBELL), Spanish Clinical Research Network, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Hereu+P%22">Hereu P</searchLink>; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Clinical Pharmacology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Clinical Research and Clinical Trial Unit (UICEC-IDIBELL), Spanish Clinical Research Network, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Corbella+X%22">Corbella X</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101648047%22">Frontiers in medicine</searchLink> [Front Med (Lausanne)] 2021 Jun 14; Vol. 8, pp. 691712. <i>Date of Electronic Publication: </i>2021 Jun 14 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101648047 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2296-858X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222296858X%22">2296858X </searchLink><i>NLM ISO Abbreviation: </i>Front Med (Lausanne) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34195214
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fmed.2021.691712
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 691712
    Titles:
      – TitleFull: Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Solanich X
      – PersonEntity:
          Name:
            NameFull: Antolí A
      – PersonEntity:
          Name:
            NameFull: Rocamora-Blanch G
      – PersonEntity:
          Name:
            NameFull: Padullés N
      – PersonEntity:
          Name:
            NameFull: Fanlo-Maresma M
      – PersonEntity:
          Name:
            NameFull: Iriarte A
      – PersonEntity:
          Name:
            NameFull: Mitjavila F
      – PersonEntity:
          Name:
            NameFull: Capdevila O
      – PersonEntity:
          Name:
            NameFull: Riera-Mestre A
      – PersonEntity:
          Name:
            NameFull: Bas J
      – PersonEntity:
          Name:
            NameFull: Vicens-Zygmunt V
      – PersonEntity:
          Name:
            NameFull: Niubó J
      – PersonEntity:
          Name:
            NameFull: Calvo N
      – PersonEntity:
          Name:
            NameFull: Bolivar S
      – PersonEntity:
          Name:
            NameFull: Rigo-Bonnin R
      – PersonEntity:
          Name:
            NameFull: Mensa-Vilaró A
      – PersonEntity:
          Name:
            NameFull: Arregui L
      – PersonEntity:
          Name:
            NameFull: Tebe C
      – PersonEntity:
          Name:
            NameFull: Videla S
      – PersonEntity:
          Name:
            NameFull: Hereu P
      – PersonEntity:
          Name:
            NameFull: Corbella X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 06
              Text: 2021 Jun 14
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2296-858X
          Numbering:
            – Type: volume
              Value: 8
          Titles:
            – TitleFull: Frontiers in medicine
              Type: main
ResultId 1